Skip to content

Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus

Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07463859
Enrollment
32
Registered
2026-03-11
Start date
2026-04-02
Completion date
2027-02-28
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Halitosis, Periodontitis, Type 2 Diabetes

Keywords

Halitosis, periodontitis, lasers, Photodynamic Therapy

Brief summary

The goal of this clinical trial is to evaluate the effectiveness of periodontal treatment associated with the use of a tongue scraper, compared with the same treatment combined with antimicrobial photodynamic therapy (aPDT), in reducing halitosis in individuals with periodontal disease and type 2 diabetes mellitus. The main question it aims to answer is: aPDT treatment is more effective in treating halitosis? aPDT treatment is more effective in periodontitis? Researchers will compare aPDT treatment to conventional treatment (scaling and root planning and tongue scraper) to see if aPDT has additional effects in reducing halitosis and improving periodontal health. * Participants will be asked to visit the clinic once a week for exam and treatment during 1 month. * After active treatment they will be asked to come to maintenance and control visits once a month until 6 months.

Interventions

PROCEDUREScaling and root planing

Mechanical removal of biofilm in periodontal pockets and tongue

Antimicrobial photodynamic therapy in periodontal pockets and tongue

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Simulation of laser treatment

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with type 2 diabetes mellitus according to the 2019 WHO criteria * Stage 3 or 4 periodontitis * No periodontal treatment in the previous 12 months * a minimum of 20 remaining teeth.

Exclusion criteria

* Smokers * Alcohol-dependent individuals * Pregnant or lactating women * Patients with renal disorders * Patients using medications that affect the periodontium

Design outcomes

Primary

MeasureTime frameDescription
HalitosisFrom enrollment to the end of treatment at 6 monthsMeasurement of oral volatile compounds by gas chromatography

Secondary

MeasureTime frameDescription
Probing depthFrom enrollment to the end of treatment at 6 monthsMeasurement in milimeters of the periodontal pocket
Clinical Attachment levelFrom enrollment to the end of treatment at 6 monthsMeasuremet in milimeters from cementoenamel junction to bottom of the pocket

Countries

Brazil

Contacts

CONTACTCarla A. Damante, PhD
cdamante@usp.br+551432266064

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026